Fig. 4

Mice immunized with rTe-β-tubulin are better protected from a lethal challenge with T. evansi. The rTe-β-tubulin immunized mice demonstrated lower parasitemia (a) and prolonged survival (b) following a virulent T. evansi challenge compared with similarly challenged adjuvant only controls. Daily counts of bloodstream trypomastigotes represent means ± s.e.m. from at least 10 mice per treatment